+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Market by CRISPR (Cas12, Cas13, Cas9), Technology (Antisense oligonucleotides, CRISPR-Cas9, Meganucleases), Application, End User - Global Forecast 2025-2030- Product Image
Gene Editing Market by CRISPR (Cas12, Cas13, Cas9), Technology (Antisense oligonucleotides, CRISPR-Cas9, Meganucleases), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Gene Editing Market by CRISPR (Cas12, Cas13, Cas9), Technology (Antisense oligonucleotides, CRISPR-Cas9, Meganucleases), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6017517
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gene editing is rapidly redefining possibilities across biotechnology and pharmaceutical fields, placing advanced genomic modification tools at the heart of emerging therapeutic, diagnostic, and agricultural innovations. Senior stakeholders seeking to navigate this dynamic landscape require targeted insight into the technologies, regulatory pressures, and strategic opportunities shaping global growth.

Market Snapshot: Gene Editing Market Size & Growth

The gene editing market grew from USD 9.18 billion in 2024 to USD 10.89 billion in 2025, and is projected to advance at a CAGR of 18.10%, reaching USD 24.92 billion by 2030. This strong growth trajectory reflects surging demand in both research and clinical arenas, driven by precision medicine initiatives, bioproduction efficiencies, and novel agricultural solutions. Expansion is further supported by consistent investment from public and private actors and maturing regulatory responses.

Scope & Segmentation of the Gene Editing Market

  • CRISPR Subtypes: Cas9, Cas12, Cas13—each enabling unique genome and RNA editing applications.
  • Technology Types: CRISPR-Cas9, RNA-guided nucleases, TALENs, antisense oligonucleotides, ZFNs, meganucleases. These platforms bring varied strengths in editing precision, delivery vehicle compatibility, and intellectual property positioning.
  • Applications: Animal genetic engineering, plant genetic engineering, cell line engineering, drug development, diagnostics, vaccine development, bioenergy, basic research, gene editing. Application relevance extends from early-stage discovery to value-added commercial and clinical endpoints.
  • End User Domains: Academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations (CROs). Each group contributes distinct capabilities and strategic perspectives.
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, United Arab Emirates, South Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asian countries).
  • Leading Companies Profiled: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Illumina, Inc., Lonza Group AG, GenScript Biotech Corporation, Bio-Rad Laboratories, Inc., New England Biolabs, Inc.

Key Takeaways for Senior Leaders

  • Gene editing technologies have transitioned from experimental platforms to drivers of next-generation biotherapeutics, agricultural productivity, and rapid diagnostic innovation.
  • CRISPR systems—including Cas9, Cas12, and Cas13—are differentiated by their capacity for genome versus RNA targeting, allowing for flexible toolkits matched to complex research and clinical objectives.
  • Collaborative partnerships between academia, pharmaceutical firms, and contract research organizations accelerate the translation of discoveries, supported by multi-disciplinary innovation hubs focused on clinical application.
  • Regulatory dynamics vary significantly by region, influencing speed to market and shaping the competitive landscape. Active engagement with policy developments is critical for sustaining pipeline momentum.
  • Companies with robust delivery technologies and scalable infrastructure are positioned to achieve process efficiencies and capture emerging opportunities in immuno-oncology, rare disease therapy, and distributed bio-manufacturing.
  • Supplier diversification and agile procurement are becoming essential as organizations respond to evolving trade and tariff realities, applying broader risk-management frameworks to research supply chains.

Tariff Impact: Implications for Research & Supply Chains

The introduction of higher United States tariffs in 2025 on key bioreagents and specialized kits has elevated material costs and supply chain complexity for gene editing operations. Organizations are actively renegotiating procurement terms, establishing strategic partnerships with regional suppliers, and centralizing distribution in tariff-exempt areas to maintain timelines and financial resilience. Smaller academic and early-stage ventures are increasingly adopting digital modeling and alternative assay methods to sustain discovery despite budget constraints.

Gene Editing Market: Primary Keyword Integration

The gene editing market continues to mature as global stakeholders invest in scalable manufacturing, regulatory readiness, and collaborative innovation to unlock therapeutic and commercial value.

Methodology & Data Sources

This research employs a multi-stage approach combining secondary literature review, direct interviews with leading experts across academia, regulatory agencies, and industry, and data triangulation using financial disclosures and press releases. A final validation phase with industry veterans ensured alignment of insights with current market realities.

Why This Report Matters

  • Delivers actionable intelligence for investment prioritization, technology scouting, and partnership evaluation in a rapidly evolving global market.
  • Equips executives with clarity on regulatory hurdles, competitive differentiators, and the strategic imperatives driving sector growth across regions and end-use segments.

Conclusion

Decision-makers armed with these insights can confidently allocate resources, mitigate operational risks, and position their organizations at the forefront of innovation in the gene editing market. Strategic agility and disciplined execution remain vital for realizing gene editing’s full impact across healthcare, research, and agriculture.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid commercialization of CRISPR base editing platforms for precision therapy applications
5.2. Integration of AI driven bioinformatics in gene editing workflows to optimize target selection
5.3. Growth of in vivo gene editing therapies targeting rare genetic disorders with high unmet needs
5.4. Emerging regulatory frameworks harmonizing global approval processes for gene edited products
5.5. Advancements in delivery systems enhancing in vivo CRISPR Cas component targeting efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Editing Market, by CRISPR
8.1. Introduction
8.2. Cas12
8.3. Cas13
8.4. Cas9
9. Gene Editing Market, by Technology
9.1. Introduction
9.2. Antisense oligonucleotides
9.3. CRISPR-Cas9
9.4. Meganucleases
9.5. RNA-guided nucleases
9.6. TALENs (Transcription Activator-Like Effector Nucleases)
9.7. ZFNs (Zinc Finger Nucleases)
10. Gene Editing Market, by Application
10.1. Introduction
10.2. Animal Genetic Engineering
10.3. Basic Research
10.4. Bioenergy
10.5. Cell Line Engineering
10.6. Diagnostics
10.7. Drug Development
10.8. Gene Editing
10.9. Plant Genetic Engineering
10.10. Vaccine Development
11. Gene Editing Market, by End User
11.1. Introduction
11.2. Academic & Government Research Institutes
11.3. Biotechnology & Pharmaceutical Companies
11.4. Contract Research Organizations (CROs)
12. Americas Gene Editing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gene Editing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gene Editing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Merck KGaA
15.3.4. PerkinElmer, Inc.
15.3.5. Agilent Technologies, Inc.
15.3.6. Illumina, Inc.
15.3.7. Lonza Group AG
15.3.8. GenScript Biotech Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. New England Biolabs, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENE EDITING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GENE EDITING MARKET: RESEARCHAI
FIGURE 24. GENE EDITING MARKET: RESEARCHSTATISTICS
FIGURE 25. GENE EDITING MARKET: RESEARCHCONTACTS
FIGURE 26. GENE EDITING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENE EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENE EDITING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENE EDITING MARKET SIZE, BY CAS12, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENE EDITING MARKET SIZE, BY CAS12, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENE EDITING MARKET SIZE, BY CAS13, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENE EDITING MARKET SIZE, BY CAS13, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENE EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENE EDITING MARKET SIZE, BY CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENE EDITING MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENE EDITING MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR-CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR-CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENE EDITING MARKET SIZE, BY RNA-GUIDED NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENE EDITING MARKET SIZE, BY RNA-GUIDED NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENE EDITING MARKET SIZE, BY TALENS (TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES), BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENE EDITING MARKET SIZE, BY TALENS (TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES), BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENE EDITING MARKET SIZE, BY ZFNS (ZINC FINGER NUCLEASES), BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENE EDITING MARKET SIZE, BY ZFNS (ZINC FINGER NUCLEASES), BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENE EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENE EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENE EDITING MARKET SIZE, BY BIOENERGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENE EDITING MARKET SIZE, BY BIOENERGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENE EDITING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENE EDITING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENE EDITING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENE EDITING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENE EDITING MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENE EDITING MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENE EDITING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENE EDITING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENE EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENE EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 80. CANADA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 81. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. CANADA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 88. MEXICO GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 89. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GERMANY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 130. GERMANY GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 131. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. FRANCE GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 138. FRANCE GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 139. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. RUSSIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 146. RUSSIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 147. RUSSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. RUSSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ITALY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 154. ITALY GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 155. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. ITALY GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ITALY GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. SPAIN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 162. SPAIN GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 163. SPAIN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. SPAIN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. SPAIN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. SPAIN GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. SPAIN GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. SPAIN GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 178. SAUDI ARABIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. SAUDI ARABIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. SAUDI ARABIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. SAUDI ARABIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 186. SOUTH AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. SOUTH AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. SOUTH AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. SOUTH AFRICA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. DENMARK GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 194. DENMARK GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 195. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. NETHERLANDS GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 202. NETHERLANDS GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 203. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. QATAR GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 210. QATAR GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 211. QATAR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. QATAR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. QATAR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. QATAR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. QATAR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. QATAR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FINLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 218. FINLAND GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 219. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SWEDEN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 226. SWEDEN GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 227. SWEDEN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. SWEDEN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. SWEDEN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. SWEDEN GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. SWEDEN GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. SWEDEN GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. NIGERIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 234. NIGERIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 235. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. NIGERIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. NIGERIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. EGYPT GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 242. EGYPT GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 243. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. TURKEY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 250. TURKEY GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 251. TURKEY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. TURKEY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. TURKEY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. TURKEY GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. TURKEY GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. TURKEY GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ISRAEL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 258. ISRAEL GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 259. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NORWAY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 266. NORWAY GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 267. NORWAY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. NORWAY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. NORWAY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. NORWAY GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. NORWAY GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NORWAY GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. POLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 274. POLAND GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 275. POLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. POLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. POLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. POLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. POLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. POLAND GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SWITZERLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 282. SWITZERLAND GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 283. SWITZERLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. SWITZERLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. SWITZERLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SWITZERLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SWITZERLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SWITZERLAND GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 290. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 298. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 299. CHINA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 300. CHINA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 301. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. CHINA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. CHINA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. INDIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 308. INDIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 309. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. INDIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. INDIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. JAPAN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 316. JAPAN GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 317. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. AUSTRALIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 324. AUSTRALIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 325. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. SOUTH KOREA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 332. SOUTH KOREA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 333. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 334. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 335. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. INDONESIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 340. INDONESIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 341. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 342. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 343. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. THAILAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 348. THAILAND GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 349. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 350. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 351. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. PHILIPPINES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 356. PHILIPPINES GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 357. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 358. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 359. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 360. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 361. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. MALAYSIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 364. MALAYSIA GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 365. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 366. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 367. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 368. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 369. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 370. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 371. SINGAPORE GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 372. SINGAPORE GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 373. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 374. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 375. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 376. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 377. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 378. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 379. VIETNAM GENE EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 380. VIETNAM GENE EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 381. VIETNAM GENE EDITING MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Editing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Lonza Group AG
  • GenScript Biotech Corporation
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.92 Billion
Compound Annual Growth Rate18.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR Gene Editing Market by Type (Base Editing, Cas9, Cpf1), Application (Agriculture, Industrial & Energy, Research & Development), End User, Delivery Method - Global Forecast 2025-2030 - Product Image

CRISPR Gene Editing Market by Type (Base Editing, Cas9, Cpf1), Application (Agriculture, Industrial & Energy, Research & Development), End User, Delivery Method - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
CRISPR & Cas Genes Market by Application (Agricultural Biotechnology, Animal Model Development, Diagnostics), End User (Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies), Cas Type, Delivery Method, Technology - Global Forecast 2025-2030 - Product Image

CRISPR & Cas Genes Market by Application (Agricultural Biotechnology, Animal Model Development, Diagnostics), End User (Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies), Cas Type, Delivery Method, Technology - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Gene Editing - Global Strategic Business Report - Product Image

Gene Editing - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.